Curcuminoids Suppress the Growth of Pharynx and Nasopharyngeal Carcinoma Cells through Induced Apoptosis

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 9, 2009, Pages 3765-3770

  Lin, Yo Tsai ^a   Wang, Leng Fang ^b   Hsu, Yi Chiang ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Curcuminoids; Nasopharyngeal carcinoma (NPC)

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL DIVISION; DNA FRAGMENTATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; PHARYNX CANCER; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CELL DIVISION; CELL LINE, TUMOR; CURCUMIN; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NASOPHARYNGEAL NEOPLASMS; NF-KAPPA B; PHARYNGEAL NEOPLASMS;

EID: 66149148764     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf803758x     Document Type: Article

References (34)

1. Khor, T. O.; Keum, Y. S.; Lin, W..; et al. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res. 2006, 66, 613-621.
2. Ray, A. Cancer preventive role of selected dietary factors. Indian J. Cancer 2005, 42, 15-24.
3. Sinha, R.; Anderson, D. E.; McDonald, S. S.; Greenwald, P. Cancer risk and diet in India. J. Postgrad. Med. 2003, 49, 222-228.
4. Perkins, S.; Verschoyle, R. D.; Hill, K..; et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 535-540.
5. Eckert, R. L.; Crish, J. F.; Efimova, T.; Balasubramanian, S. Antioxidants regulate normal human keratinocyte differentiation. Biochem. Pharmacol. 2004, 68, 1125-1131.
6. Sandur, S. K.; Pandey, M. K.; Sung, B..; et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate antiinflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 2007, 28, 1765-1773.
7. Atsumi, T.; Tonosaki, K.; Fujisawa, S. Comparative cytotoxicity and ROS generation by curcumin and tetrahydrocurcumin following visible-light irradiation or treatment with horseradish peroxidase. Anticancer Res. 2007, 27, 363-371.
8. Cole, G. M.; Teter, B.; Frautschy, S. A. Neuroprotective effects of curcumin. Adv. Exp. Med. Biol. 2007, 595, 197-212.
9. Jagetia, G. C.; Aggarwal, B. B. "Spicing up" of the immune system by curcumin. J. Clin. Immunol. 2007, 27, 19-35.
10. Shishodia, S.; Singh, T.; Chaturvedi, M. M. Modulation of transcription factors by curcumin. Adv. Exp. Med. Biol. 2007, 595, 127-148.
11. Sandur, S. K.; Ichikawa, H.; Pandey, M. K..; et al. Role of prooxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radical Biol. Med. 2007, 43, 568-580.
12. Tang, Y.; Li, J.; Zhao, S.; Liu, J. Killing effect of the herpes simplex virus thymidine kinase/ganciclovir enzyme/prodrug system on human nasopharyngeal carcinoma cells. J. Int. Med. Res. 2007, 35, 433-441.
13. Luangdilok, S.; Box, C.; Patterson, L..; et al. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer Res. 2007, 67, 7907-7916.
14. Elser, C.; Siu, L. L.; Winquist, E..; et al. Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma. J. Clin. Oncol. 2007, 25, 3766-3773.
15. Thangapazham, R. L.; Sharma, A.; Maheshwari, R. K. Beneficial role of curcumin in skin diseases. Adv. Exp. Med. Biol. 2007, 595, 343-357.
16. Jagetia, G. C.; Rajanikant, G. K. Effect of curcumin on radiation-impaired healing of excisional wounds in mice. J. Wound Care 2004, 13, 107-109.
17. Aggarwal, B. B.; Sundaram, C.; Malani, N.; Ichikawa, H. Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 2007, 595, 1-75.
18. Hsu, Y. C.; Weng, H. C.; Lin, S. R.; Chien, Y. W. Curcuminoids; cellular uptake by human primarycolon cancer cells as quantitated by a sensitive HPLC assay and its relation with the inhibition of proliferation and apoptosis. J. Agric. Food Chem. 2007, 55, 8213-8222.
19. Surh, Y. J.; Chun, K. S. Cancer chemopreventive effects of curcumin. Adv. Exp. Med. Biol. 2007, 595, 149-172.
20. Cao, J.; Liu, Y.; Jia, L..; et al. Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells. Free Radical Biol. Med. 2007, 43, 968-975.
21. Sharma, R. A.; Steward, W. P.; Gescher, A. J. Pharmacokinetics and pharmacodynamics of curcumin. Adv. Exp. Med. Biol. 2007, 595, 453-470.
22. Limtrakul, P. Curcumin as chemosensitizer. Adv. Exp. Med. Biol. 2007, 595, 269-300.
23. Park, C.; Moon, D. O.; Choi, I. W..; et al. Curcumin induces apoptosis and inhibits prostaglandin E2 production in synovial fibroblasts of patients with rheumatoid arthritis. Int. J. Mol. Med. 2007, 20, 365-372.
24. Divya, C. S.; Pillai, M. R. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol. Carcinog. 2006, 45, 320-332.
25. Dempe, J. S.; Pfeiffer, E.; Grimm, A. S.; Metzler, M. Metabolism of curcumin and induction of mitotic catastrophe in human cancer cells. Mol. Nutr. Food Res. 2008, 52, 1074-1081.
26. Sikora, E.; Bielak-Zmijewska, A.; Magalska, A.; Piwocka, K.; Mosieniak, G.; Kalinowska, M.; Widlak, P.; Cymerman, I. A.; Bujnicki, J. M. Curcumin induces caspase-3-dependent apoptotic pathway but inhibits DNA fragmentation factor 40/caspase-activated DNase endonuclease in human Jurkat cells. Mol. Cancer Ther. 2006, 5, 927-934.
27. Magalska, A.; Brzezinska, A.; Bielak-Zmijewska, A..; et al. Curcumin induces cell death without oligonucleosomal DNA fragmentation in quiescent and proliferating human CD8+cells. Acta Biochim. Pol. 2006, 53, 531-538.
28. Kuttan, G.; Kumar, K. B.; Guruvayoorappan, C.; Kuttan, R. Antitumor, anti-invasion, and antimetastatic effects of curcumin. Adv. Exp. Med. Biol. 2007, 595, 173-184.
29. Kunnumakkara, A. B.; Guha, S.; Krishnan, S..; et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-?B-regulated gene products. Cancer Res. 2007, 67, 3853-3861.
30. Yoon, H.; Liu, R. H. Effect of selected phytochemicals and apple extracts on NF-?B activation in human breast cancer MCF-7 cells. J. Agric. Food Chem. 2007, 55, 3167-3173.
31. Sharma, R. A.; McLelland, H. R.; Hill, K. A.; Ireson, C. R.; Euden, S. A.; Manson, M. M.; Pirmohamed, M.; Marnett, L. J.; Gescher, A. J.; Steward, W. P. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 2001, 7, 1894-1900.
32. Koon, H.; Leung, A. W.; Yue, K. K.; Mak, N. K. Photodynamic effect of curcumin on NPC/CNE2 cells. J. Environ. Pathol. Toxicol. Oncol. 2006, 25, 205-215.
33. Nakagawa-Goto, K.; Yamada, K.; Nakamura, S.; Chen, T. H.; Chiang, P. C.; Bastow, K. F.; Wang, S. C.; Spohn, B.; Hung, M. C.; Lee, F. Y.; Lee, F. C.; Lee, K. H. Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant;taxoid conjugates as novel cytotoxic agents. Bioorg. Med. Chem. Lett. 2007, 17, 5204-5209.
34. Salmaso, S.; Bersani, S.; Semenzato, A.; Caliceti, P. New cyclodextrin bioconjugates for active tumour targeting. J. Drug Target. 2007, 15, 379-390.